Funded Startups in Maastricht
Among the 7 most recent funded startups tied to Maastricht, the only disclosed round above $25M is Mosa Meat’s $42M on 2024-04-16; the next-largest disclos…
Among the 7 most recent funded startups tied to Maastricht, the only disclosed round above $25M is Mosa Meat’s $42M on 2024-04-16; the next-largest disclosed amount is Qorium’s $25M on 2025-11-13, with the remaining disclosed rounds at $4M (Corporis Medical on 2023-12-07), $2M (Ansana on 2025-09-29 and OncoLize on 2023-04-13), and $760K (Aerial Precision on 2022-08-25). A second pattern is concentration in a tight time window: four rounds fall between 2023-04-13 and 2024-04-16 (OncoLize 2023-04-13, Corporis Medical 2023-12-07, Mosa Meat 2024-01-10/2024-04-16), while the two newest disclosed rounds cluster in late 2025 (Ansana 2025-09-29 and Qorium 2025-11-13). Sector-wise, healthcare-related entries dominate the list: 4 of 7 companies are in healthcare/health care (Ansana, Corporis Medical, OncoLize, and Qorium’s biotech/health overlap), while 2 are in agriculture/farming or consumer/consumer electronics and 1 is in fashion/consumer goods. Dates span 2022-08-25 through 2025-11-13, with Series Unknown appearing 2 times and an undisclosed amount appearing 1 time.
Most recent rounds
7 shownRelated listings
Frequently asked
What’s the largest disclosed round in the Maastricht list, and how does it compare to the rest of the disclosed amounts?
Mosa Meat’s $42M on 2024-04-16 is the largest disclosed amount shown, and it sits well above the next-largest disclosed round of $25M (Qorium on 2025-11-13). After those, disclosed rounds drop to $4M (Corporis Medical on 2023-12-07), $2M (Ansana on 2025-09-29; OncoLize on 2023-04-13), and $760K (Aerial Precision on 2022-08-25).
Do rounds cluster in a specific date window rather than spreading evenly across 2022–2025?
Yes. Four of the seven entries have round dates between 2023-04-13 and 2024-04-16 (OncoLize 2023-04-13, Corporis Medical 2023-12-07, Qorium 2024-01-10, and Mosa Meat 2024-04-16). The other three entries bookend later activity, with two in late 2025 (Ansana 2025-09-29; Qorium 2025-11-13) and one in 2022 (Aerial Precision 2022-08-25).
Is any stage classification over-represented among these Maastricht-based rounds?
The most frequent explicit stage is Seed, with 3 of 7 entries marked Seed (Ansana 2025-09-29 for $2M, OncoLize 2023-04-13 for $2M, and Aerial Precision 2022-08-25 for $760K). Series Unknown appears 2 times (Mosa Meat on 2024-04-16 for $42M and Qorium on 2024-01-10 as undisclosed), while a single Series A and a single Series B appear (Qorium 2025-11-13 for $25M; Corporis Medical 2023-12-07 for $4M).
Are healthcare-related sectors over-represented compared with other verticals in this list?
Healthcare/health care appears in 4 of 7 companies: Ansana, Corporis Medical, OncoLize, and Qorium (listed as Biotechnology and also tied to healthcare-adjacent themes in its categorization). The remaining entries split across agriculture/farming (Mosa Meat on 2024-04-16), consumer electronics (Aerial Precision on 2022-08-25), and consumer goods/fashion plus biotechnology (Qorium on 2025-11-13).
Are there outliers in amount or disclosure status that stand out for investigation?
Two outliers show up. Amount-wise, Mosa Meat’s $42M (2024-04-16) is far above most other disclosed rounds, while the smallest disclosed amount is Aerial Precision’s $760K (2022-08-25). Disclosure-wise, Qorium appears twice with different visibility: a disclosed $25M Series A on 2025-11-13 and an additional 2024-01-10 entry marked “undisclosed,” alongside 2 entries labeled “Series Unknown” (Mosa Meat 2024-04-16 for $42M and Qorium 2024-01-10 as undisclosed).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.